Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.
Journal: Haematologica
Published: April 22, 2026
Menin inhibition reshapes therapy in NPM1-mutated acute myeloid leukemia.
Journal: Annals of translational medicine
Published: March 14, 2026
Post-transplant oral decitabine and cedazuridine maintenance in high-risk acute myeloid leukemia or myelodysplastic syndrome.
Journal: Translational cancer research
Published: January 15, 2026
HSR25-172: Meta-Analysis of Phase 3 Randomized Controlled Trials to Evaluate the Incidence of Infectious Adverse Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Belantamab Mafodotin.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
HSR25-143: Meta-Analysis of Phase 3 Randomized Controlled Trials to Evaluate the Incidence of Systemic Toxicities in Patients With Relapsed/Refractory Multiple Myeloma Treated With Belantamab Mafodotin.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
A systematic review and meta-analysis of phase III randomized controlled trials to assess the risk of pneumonia, URTIs, and VTE in multiple myeloma patients treated with isatuximab.
Journal: Exploration of targeted anti-tumor therapy
Published: December 10, 2024
Hyperhomocysteinemia-associated Thrombosis in Patients With Pernicious Anemia.
Journal: Journal of community hospital internal medicine perspectives
Published: August 12, 2024
Updated meta-analysis of randomized controlled trials on primary outpatient thromboprophylaxis in patients with gastric and gastroesophageal junction cancers receiving chemotherapy.
Journal: Proceedings (Baylor University. Medical Center)
Published: August 24, 2023
Meta-analysis of randomized controlled trials on primary ambulatory thromboprophylaxis in patients with ovarian cancer receiving chemotherapy.
Journal: Proceedings (Baylor University. Medical Center)
Published: May 06, 2022
Meta-analysis of randomized controlled trials on primary ambulatory thromboprophylaxis in patients with nonpancreatic gastrointestinal cancers receiving chemotherapy.
Journal: Proceedings (Baylor University. Medical Center)
Published: December 31, 2021
Primary ambulatory thromboprophylaxis in patients with pancreatic cancer receiving chemotherapy: hope or hype?
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 19, 2021
Last Updated: 09/26/2026